$LJPC Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in LA JOLLA PHARMACEUTICAL CO.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in LA JOLLA PHARMACEUTICAL CO. Get notifications about new insider transactions in LA JOLLA PHARMACEUTICAL CO for free.
Page: < prev 1 ... 2 3 4 5 6 7 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 03 2016 | LJPC | LA JOLLA PHARMACEU ... | TIDMARSH GEORGE F | President, CEO & Se ... | Buy | P | 16.64 | 1,000 | 16,640 | 1,425,086 | 1.4 M to 1.4 M (+0.07 %) |
| Mar 03 2016 | LJPC | LA JOLLA PHARMACEU ... | TIDMARSH GEORGE F | President, CEO & Se ... | Buy | P | 16.50 | 1,000 | 16,500 | 1,424,086 | 1.4 M to 1.4 M (+0.07 %) |
| Dec 23 2015 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Option Exercise | A | 28.24 | 10,000 | 282,400 | 10,000 | |
| Dec 23 2015 | LJPC | LA JOLLA PHARMACEU ... | Rosen Robert | Director | Option Exercise | A | 28.24 | 10,000 | 282,400 | 10,000 | |
| Dec 23 2015 | LJPC | LA JOLLA PHARMACEU ... | Johnson Craig A | Director | Option Exercise | A | 28.24 | 10,000 | 282,400 | 10,000 | |
| Dec 23 2015 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Option Exercise | A | 28.24 | 58,700 | 1,657,688 | 58,700 | |
| Dec 23 2015 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 28.24 | 41,500 | 1,171,960 | 41,500 | |
| Dec 23 2015 | LJPC | LA JOLLA PHARMACEU ... | Douglass Laura L. | Director | Option Exercise | A | 28.24 | 10,000 | 282,400 | 10,000 | |
| Dec 23 2015 | LJPC | LA JOLLA PHARMACEU ... | TIDMARSH GEORGE F | President, CEO & Se ... | Option Exercise | A | 28.24 | 289,000 | 8,161,360 | 289,000 | |
| Sep 30 2015 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Buy | P | 27.75 | 485 | 13,461 | 485 | 0 to 485 |
| Sep 14 2015 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 38.00 | 80,000 | 3,040,000 | 2,872,130 | 2.8 M to 2.9 M (+2.87 %) |
| Sep 02 2015 | LJPC | LA JOLLA PHARMACEU ... | TIDMARSH GEORGE F | President, CEO & Se ... | Option Exercise | A | 35.58 | 40,000 | 1,423,200 | 40,000 | |
| Sep 02 2015 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Option Exercise | A | 35.58 | 40,000 | 1,423,200 | 40,000 | |
| Sep 02 2015 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Option Exercise | A | 35.58 | 60,000 | 2,134,800 | 60,000 | |
| Aug 21 2015 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 29.94 | 10,000 | 299,413 | 2,792,130 | 2.8 M to 2.8 M (+0.36 %) |
| Aug 21 2015 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 28.25 | 10,000 | 282,505 | 2,782,130 | 2.8 M to 2.8 M (+0.36 %) |
| Aug 21 2015 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 27.82 | 10,000 | 278,150 | 2,772,130 | 2.8 M to 2.8 M (+0.36 %) |
| Aug 21 2015 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 26.73 | 10,000 | 267,280 | 2,762,130 | 2.8 M to 2.8 M (+0.36 %) |
| Aug 21 2015 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 25.72 | 10,000 | 257,167 | 2,752,130 | 2.7 M to 2.8 M (+0.36 %) |
| Aug 21 2015 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 26.54 | 10,000 | 265,448 | 2,742,130 | 2.7 M to 2.7 M (+0.37 %) |
| Aug 21 2015 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 26.85 | 10,000 | 268,549 | 2,732,130 | 2.7 M to 2.7 M (+0.37 %) |
| Aug 21 2015 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 26.97 | 10,000 | 269,710 | 2,722,130 | 2.7 M to 2.7 M (+0.37 %) |
| Aug 21 2015 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 26.66 | 10,000 | 266,583 | 2,712,130 | 2.7 M to 2.7 M (+0.37 %) |
| Aug 21 2015 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 27.17 | 10,000 | 271,685 | 2,702,130 | 2.7 M to 2.7 M (+0.37 %) |
| Aug 21 2015 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 27.59 | 30,000 | 827,697 | 2,692,130 | 2.7 M to 2.7 M (+1.13 %) |
| Aug 21 2015 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 26.98 | 10,000 | 269,782 | 2,662,130 | 2.7 M to 2.7 M (+0.38 %) |
| Aug 21 2015 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 26.26 | 10,000 | 262,585 | 2,652,130 | 2.6 M to 2.7 M (+0.38 %) |
| Aug 21 2015 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 26.13 | 20,000 | 522,676 | 2,642,130 | 2.6 M to 2.6 M (+0.76 %) |
| Jun 30 2015 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 23.58 | 110,000 | 2,593,470 | 2,622,130 | 2.5 M to 2.6 M (+4.38 %) |
| Jun 24 2015 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 22.94 | 88,314 | 2,026,188 | 2,512,130 | 2.4 M to 2.5 M (+3.64 %) |
| Jun 24 2015 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 22.27 | 53,836 | 1,198,739 | 2,423,816 | 2.4 M to 2.4 M (+2.27 %) |
| Jun 24 2015 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 21.41 | 77,850 | 1,666,597 | 2,369,980 | 2.3 M to 2.4 M (+3.40 %) |
| May 15 2015 | LJPC | LA JOLLA PHARMACEU ... | Zarrabian Saiid | Director | Buy | P | 19.50 | 307 | 5,987 | 688 | 381 to 688 (+80.58 %) |
| May 13 2015 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 18.63 | 47,483 | 884,532 | 2,292,130 | 2.2 M to 2.3 M (+2.12 %) |
| May 13 2015 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 18.25 | 44,400 | 810,362 | 2,244,647 | 2.2 M to 2.2 M (+2.02 %) |
| May 13 2015 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 18.04 | 98,700 | 1,780,548 | 2,200,247 | 2.1 M to 2.2 M (+4.70 %) |
| May 13 2015 | LJPC | LA JOLLA PHARMACEU ... | TIDMARSH GEORGE F | President, CEO & Se ... | Buy | P | 18.36 | 2,000 | 36,720 | 1,423,086 | 1.4 M to 1.4 M (+0.14 %) |
| May 13 2015 | LJPC | LA JOLLA PHARMACEU ... | TIDMARSH GEORGE F | President, CEO & Se ... | Buy | P | 18.38 | 2,000 | 36,760 | 22,000 | 20 K to 22 K (+10.00 %) |
| Apr 08 2015 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 18.23 | 60,000 | 1,093,800 | 60,000 | |
| Feb 25 2015 | LJPC | LA JOLLA PHARMACEU ... | Douglass Laura L. | Director | Option Exercise | A | 19.69 | 10,000 | 196,900 | 10,000 | |
| Feb 25 2015 | LJPC | LA JOLLA PHARMACEU ... | Johnson Craig A | Director | Option Exercise | A | 19.69 | 10,000 | 196,900 | 10,000 | |
| Feb 25 2015 | LJPC | LA JOLLA PHARMACEU ... | Rosen Robert | Director | Option Exercise | A | 19.69 | 10,000 | 196,900 | 10,000 | |
| Feb 25 2015 | LJPC | LA JOLLA PHARMACEU ... | Zarrabian Saiid | Director | Option Exercise | A | 19.69 | 10,000 | 196,900 | 10,000 | |
| Feb 25 2015 | LJPC | LA JOLLA PHARMACEU ... | TIDMARSH GEORGE F | President, CEO & Se ... | Option Exercise | A | 19.69 | 300,000 | 5,907,000 | 300,000 | |
| Feb 25 2015 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Option Exercise | A | 19.69 | 10,000 | 196,900 | 10,000 | |
| Dec 18 2014 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 13.95 | 582 | 8,117 | 2,101,547 | 2.1 M to 2.1 M (+0.03 %) |
| Dec 15 2014 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 13.93 | 32,343 | 450,574 | 2,100,965 | 2.1 M to 2.1 M (+1.56 %) |
| Dec 15 2014 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 13.71 | 77,304 | 1,059,846 | 2,068,622 | 2 M to 2.1 M (+3.88 %) |
| Dec 15 2014 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 12.01 | 122,696 | 1,473,910 | 1,991,318 | 1.9 M to 2 M (+6.57 %) |
| Dec 12 2014 | LJPC | LA JOLLA PHARMACEU ... | TIDMARSH GEORGE F | President, CEO & Se ... | Buy | P | 11.38 | 4,000 | 45,520 | 1,421,086 | 1.4 M to 1.4 M (+0.28 %) |
| Oct 06 2014 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Option Exercise | A | 9.20 | 18,000 | 165,600 | 18,000 | |
| Sep 30 2014 | LJPC | LA JOLLA PHARMACEU ... | TIDMARSH GEORGE F | President, CEO & Se ... | Buy | P | 9.35 | 2,000 | 18,700 | 1,417,086 | 1.4 M to 1.4 M (+0.14 %) |
| Sep 26 2014 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 9.21 | 44,055 | 405,861 | 1,868,622 | 1.8 M to 1.9 M (+2.41 %) |
| Sep 26 2014 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 9.17 | 30,500 | 279,688 | 1,824,567 | 1.8 M to 1.8 M (+1.70 %) |
| Sep 26 2014 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 9.10 | 95,000 | 864,443 | 1,794,067 | 1.7 M to 1.8 M (+5.59 %) |
| Sep 22 2014 | LJPC | LA JOLLA PHARMACEU ... | TIDMARSH GEORGE F | President, CEO & Se ... | Buy | P | 9.18 | 5,000 | 45,900 | 1,415,086 | 1.4 M to 1.4 M (+0.35 %) |
| Aug 05 2014 | LJPC | LA JOLLA PHARMACEU ... | Zarrabian Saiid | Director | Buy | P | 9.53 | 381 | 3,631 | 381 | 0 to 381 |
| Jul 25 2014 | LJPC | LA JOLLA PHARMACEU ... | TIDMARSH GEORGE F | President, CEO & Se ... | Buy | P | 10.50 | 19,000 | 199,500 | 1,410,086 | 1.4 M to 1.4 M (+1.37 %) |
| Jul 08 2014 | LJPC | LA JOLLA PHARMACEU ... | Rosen Robert | Director | Option Exercise | A | 8.52 | 18,000 | 153,360 | 18,000 | |
| May 22 2014 | LJPC | LA JOLLA PHARMACEU ... | TIDMARSH GEORGE F | President, CEO & Se ... | Buy | P | 7.37 | 12,000 | 88,440 | 20,000 | 8 K to 20 K (+150.00 %) |
| Apr 14 2014 | LJPC | LA JOLLA PHARMACEU ... | TIDMARSH GEORGE F | President, CEO & Se ... | Buy | P | 9.30 | 2,000 | 18,600 | 4,000 | 2 K to 4 K (+100.00 %) |
| Apr 14 2014 | LJPC | LA JOLLA PHARMACEU ... | TIDMARSH GEORGE F | President, CEO & Se ... | Buy | P | 9.30 | 2,000 | 18,600 | 4,000 | 2 K to 4 K (+100.00 %) |
| Apr 14 2014 | LJPC | LA JOLLA PHARMACEU ... | TIDMARSH GEORGE F | President, CEO & Se ... | Buy | P | 9.76 | 2,000 | 19,520 | 2,000 | 0 to 2 K |
| Apr 14 2014 | LJPC | LA JOLLA PHARMACEU ... | TIDMARSH GEORGE F | President, CEO & Se ... | Buy | P | 9.76 | 2,000 | 19,520 | 2,000 | 0 to 2 K |
| Apr 07 2014 | LJPC | LA JOLLA PHARMACEU ... | TIDMARSH GEORGE F | President, CEO & Se ... | Option Exercise | A | 10.84 | 100,000 | 1,084,000 | 100,000 | |
| Apr 07 2014 | LJPC | LA JOLLA PHARMACEU ... | TIDMARSH GEORGE F | President, CEO & Se ... | Option Exercise | A | 10.84 | 81,000 | 878,040 | 81,000 | |
| Apr 07 2014 | LJPC | LA JOLLA PHARMACEU ... | Johnson Craig A | Director | Option Exercise | A | 10.84 | 6,000 | 65,040 | 6,000 | |
| Apr 07 2014 | LJPC | LA JOLLA PHARMACEU ... | Johnson Craig A | Director | Option Exercise | A | 10.84 | 13,000 | 140,920 | 13,000 | |
| Apr 07 2014 | LJPC | LA JOLLA PHARMACEU ... | Zarrabian Saiid | Director | Option Exercise | A | 10.84 | 6,000 | 65,040 | 6,000 | |
| Apr 07 2014 | LJPC | LA JOLLA PHARMACEU ... | Zarrabian Saiid | Director | Option Exercise | A | 10.84 | 13,000 | 140,920 | 13,000 | |
| Apr 07 2014 | LJPC | LA JOLLA PHARMACEU ... | Douglass Laura L. | Director | Option Exercise | A | 10.84 | 6,000 | 65,040 | 6,000 | |
| Apr 07 2014 | LJPC | LA JOLLA PHARMACEU ... | Douglass Laura L. | Director | Option Exercise | A | 10.84 | 13,000 | 140,920 | 13,000 | |
| Feb 11 2014 | LJPC | LA JOLLA PHARMACEU ... | TIDMARSH GEORGE F | President, CEO & Se ... | Buy | P | 7.25 | 3,000 | 21,750 | 1,391,086 | 1.4 M to 1.4 M (+0.22 %) |
| Nov 26 2013 | LJPC | LA JOLLA PHARMACEU ... | Zarrabian Saiid | Director | Option Exercise | A | 0.12 | 900,000 | 108,000 | 900,000 | |
| Nov 26 2013 | LJPC | LA JOLLA PHARMACEU ... | Douglass Laura L. | Director | Option Exercise | A | 0.12 | 900,000 | 108,000 | 900,000 | |
| Nov 26 2013 | LJPC | LA JOLLA PHARMACEU ... | Johnson Craig A | Director | Option Exercise | A | 0.12 | 900,000 | 108,000 | 900,000 | |
| Oct 11 2013 | LJPC | LA JOLLA PHARMACEU ... | TIDMARSH GEORGE F | Pres, CEO, Sec'y | Option Exercise | D | 0.06 | 506,300,087 | 30,378,005 | 0 | |
| Oct 11 2013 | LJPC | LA JOLLA PHARMACEU ... | TIDMARSH GEORGE F | Pres, CEO, Sec'y | Grant | A | 0.00 | 66,352,429 | 0 | 68,332,871 | 2 M to 68.3 M (+3,350.38 %) |
| Oct 11 2013 | LJPC | LA JOLLA PHARMACEU ... | Zarrabian Saiid | Director | Option Exercise | D | 0.06 | 18,907,498 | 1,134,450 | 0 | |
| Oct 11 2013 | LJPC | LA JOLLA PHARMACEU ... | Zarrabian Saiid | Director | Grant | A | 0.00 | 3,981,146 | 0 | 5,461,588 | 1.5 M to 5.5 M (+268.92 %) |
| Oct 11 2013 | LJPC | LA JOLLA PHARMACEU ... | Zarrabian Saiid | Director | Sell | D | 0.00 | 10,360,892 | 0 | 1,480,442 | 11.8 M to 1.5 M (-87.50 %) |
| May 01 2013 | LJPC | LA JOLLA PHARMACEU ... | TIDMARSH GEORGE F | President and CEO | Grant | A | 0.00 | 800,000 | 0 | 1,980,442 | 1.2 M to 2 M (+67.77 %) |
| May 01 2013 | LJPC | LA JOLLA PHARMACEU ... | Zarrabian Saiid | Director | Grant | A | 0.00 | 300,000 | 0 | 1,480,442 | 1.2 M to 1.5 M (+25.41 %) |
| Mar 22 2013 | LJPC | LA JOLLA PHARMACEU ... | Reinisch Richard | Buy | P | 0.09 | 20,000 | 1,880 | 1,100,000 | 1.1 M to 1.1 M (+1.85 %) | |
| Mar 22 2013 | LJPC | LA JOLLA PHARMACEU ... | Reinisch Richard | Buy | P | 0.09 | 80,000 | 7,296 | 1,080,000 | 1000 K to 1.1 M (+8.00 %) | |
| Mar 22 2013 | LJPC | LA JOLLA PHARMACEU ... | Reinisch Richard | Buy | P | 0.10 | 220,695 | 21,341 | 1,000,000 | 779.3 K to 1000 K (+28.32 %) | |
| Mar 22 2013 | LJPC | LA JOLLA PHARMACEU ... | Reinisch Richard | Buy | P | 0.10 | 279,305 | 26,590 | 779,305 | 500 K to 779.3 K (+55.86 %) | |
| Mar 22 2013 | LJPC | LA JOLLA PHARMACEU ... | Reinisch Richard | Buy | P | 0.09 | 121,200 | 10,908 | 500,000 | 378.8 K to 500 K (+32.00 %) | |
| Mar 22 2013 | LJPC | LA JOLLA PHARMACEU ... | Reinisch Richard | Buy | P | 0.09 | 144,780 | 12,987 | 378,800 | 234 K to 378.8 K (+61.87 %) | |
| Mar 22 2013 | LJPC | LA JOLLA PHARMACEU ... | Reinisch Richard | Buy | P | 0.08 | 234,000 | 18,018 | 234,020 | 20 to 234 K (+1,170,000.00 %) | |
| Mar 22 2013 | LJPC | LA JOLLA PHARMACEU ... | Reinisch Richard | Buy | P | 936.20 | 20 | 18,724 | 20 | 0 to 20 | |
| Apr 12 2012 | LJPC | LA JOLLA PHARMACEU ... | TIDMARSH GEORGE F | President and CEO | Option Exercise | A | 0.06 | 383,530,683 | 23,011,841 | 383,530,683 | |
| Apr 12 2012 | LJPC | LA JOLLA PHARMACEU ... | TIDMARSH GEORGE F | President and CEO | Grant | A | 0.00 | 1,180,442 | 0 | 1,180,442 | 0 to 1.2 M |
| Apr 12 2012 | LJPC | LA JOLLA PHARMACEU ... | Zarrabian Saiid | Director | Option Exercise | A | 0.06 | 11,541,334 | 692,480 | 11,541,334 | |
| Apr 12 2012 | LJPC | LA JOLLA PHARMACEU ... | Zarrabian Saiid | Director | Grant | A | 0.00 | 10,360,892 | 0 | 11,541,334 | 1.2 M to 11.5 M (+877.71 %) |
| Apr 12 2012 | LJPC | LA JOLLA PHARMACEU ... | Zarrabian Saiid | Director | Grant | A | 0.00 | 1,180,442 | 0 | 1,180,442 | 0 to 1.2 M |
| May 18 2011 | LJPC | LA JOLLA PHARMACEU ... | Gillespie Deirdre | President & CEO | Option Exercise | M | 0.01 | 1 | 0 | 111 | |
| May 18 2011 | LJPC | LA JOLLA PHARMACEU ... | Gillespie Deirdre | President & CEO | Sell | S | 0.02 | 99,166 | 1,587 | 0 | 99.2 K to 0 (-100.00 %) |
| May 18 2011 | LJPC | LA JOLLA PHARMACEU ... | Gillespie Deirdre | President & CEO | Buy | M | 0.01 | 99,166 | 595 | 99,166 | 0 to 99.2 K |
| Apr 21 2011 | LJPC | LA JOLLA PHARMACEU ... | SLOAN GAIL A | Chief Financial Off ... | Sell | S | 1.00 | 100 | 100 | 980 | 1.1 K to 980 (-9.26 %) |
| Apr 21 2011 | LJPC | LA JOLLA PHARMACEU ... | SLOAN GAIL A | Chief Financial Off ... | Buy | J | 3.91 | 140 | 547 | 1,080 | 940 to 1.1 K (+14.89 %) |
| Apr 20 2011 | LJPC | LA JOLLA PHARMACEU ... | Gillespie Deirdre | President & CEO | Sell | S | 0.70 | 4,376 | 3,063 | 0 | 4.4 K to 0 (-100.00 %) |
| Dec 08 2010 | LJPC | LA JOLLA PHARMACEU ... | Liang Bertrand C. | Director | Option Exercise | A | 0.02 | 300,000 | 6,000 | 300,000 | |
| Jun 02 2010 | LJPC | LA JOLLA PHARMACEU ... | SLOAN GAIL A | Chief Financial Off ... | Option Exercise | A | 0.06 | 1,800,000 | 108,000 | 1,800,000 | |
| Jun 02 2010 | LJPC | LA JOLLA PHARMACEU ... | Gillespie Deirdre | President & CEO | Option Exercise | A | 0.06 | 4,000,000 | 240,000 | 4,000,000 | |
| Jun 02 2010 | LJPC | LA JOLLA PHARMACEU ... | MARTIN STEPHEN | Director | Option Exercise | A | 0.06 | 300,000 | 18,000 | 300,000 | |
| Jun 02 2010 | LJPC | LA JOLLA PHARMACEU ... | FILDES ROBERT PHD | Director | Option Exercise | A | 0.06 | 300,000 | 18,000 | 300,000 | |
| May 28 2010 | LJPC | LA JOLLA PHARMACEU ... | SLOAN GAIL A | Chief Financial Off ... | Option Exercise | A | 1,000.00 | 22 | 22,000 | 22 | |
| May 28 2010 | LJPC | LA JOLLA PHARMACEU ... | SLOAN GAIL A | Chief Financial Off ... | Option Exercise | A | 1,000.00 | 44 | 44,000 | 44 | |
| May 28 2010 | LJPC | LA JOLLA PHARMACEU ... | SLOAN GAIL A | Chief Financial Off ... | Option Exercise | A | 0.02 | 22 | 0 | 22 | |
| May 28 2010 | LJPC | LA JOLLA PHARMACEU ... | SLOAN GAIL A | Chief Financial Off ... | Grant | A | 0.03 | 94,038 | 2,821 | 94,038 | 0 to 94 K |
| May 28 2010 | LJPC | LA JOLLA PHARMACEU ... | Gillespie Deirdre | President & CEO | Option Exercise | A | 1,000.00 | 104 | 104,000 | 104 | |
| May 28 2010 | LJPC | LA JOLLA PHARMACEU ... | Gillespie Deirdre | President & CEO | Option Exercise | A | 1,000.00 | 208 | 208,000 | 208 | |
| May 28 2010 | LJPC | LA JOLLA PHARMACEU ... | Gillespie Deirdre | President & CEO | Option Exercise | A | 0.02 | 104 | 2 | 104 | |
| May 28 2010 | LJPC | LA JOLLA PHARMACEU ... | Gillespie Deirdre | President & CEO | Grant | A | 0.03 | 437,649 | 13,129 | 437,649 | 0 to 437.6 K |
| Jan 04 2010 | LJPC | LA JOLLA PHARMACEU ... | SLOAN GAIL A | VP of Finance | Option Exercise | A | 0.00 | 483,810 | 0 | 483,810 | |
| Jan 04 2010 | LJPC | LA JOLLA PHARMACEU ... | Gillespie Deirdre | President & CEO | Option Exercise | A | 0.00 | 1,411,898 | 0 | 1,411,898 | |
| Aug 07 2009 | LJPC | LA JOLLA PHARMACEU ... | SLOAN GAIL A | VP of Finance | Sell | S | 0.19 | 1,810 | 344 | 0 | 1.8 K to 0 (-100.00 %) |
| Aug 07 2009 | LJPC | LA JOLLA PHARMACEU ... | SUTTER MARTIN P | Director | Sell | S | 0.18 | 437,593 | 80,211 | 0 | 437.6 K to 0 (-100.00 %) |
| Aug 07 2009 | LJPC | LA JOLLA PHARMACEU ... | SUTTER MARTIN P | Director | Sell | S | 0.19 | 623,026 | 116,630 | 437,593 | 1.1 M to 437.6 K (-58.74 %) |
| Aug 07 2009 | LJPC | LA JOLLA PHARMACEU ... | SUTTER MARTIN P | Director | Sell | S | 0.18 | 386,872 | 70,914 | 0 | 386.9 K to 0 (-100.00 %) |
| Aug 07 2009 | LJPC | LA JOLLA PHARMACEU ... | SUTTER MARTIN P | Director | Sell | S | 0.19 | 792,942 | 148,439 | 368,872 | 1.2 M to 368.9 K (-68.25 %) |
| Aug 07 2009 | LJPC | LA JOLLA PHARMACEU ... | ESSEX WOODLANDS HEALTH VENTURE ... | 10% Owner | Sell | S | 0.18 | 437,593 | 80,211 | 0 | 437.6 K to 0 (-100.00 %) |
| Aug 07 2009 | LJPC | LA JOLLA PHARMACEU ... | ESSEX WOODLANDS HEALTH VENTURE ... | 10% Owner | Sell | S | 0.19 | 623,026 | 116,630 | 437,593 | 1.1 M to 437.6 K (-58.74 %) |
| Aug 07 2009 | LJPC | LA JOLLA PHARMACEU ... | ESSEX WOODLANDS HEALTH VENTURE ... | 10% Owner | Sell | S | 0.18 | 368,872 | 67,614 | 0 | 368.9 K to 0 (-100.00 %) |
| Aug 07 2009 | LJPC | LA JOLLA PHARMACEU ... | ESSEX WOODLANDS HEALTH VENTURE ... | 10% Owner | Sell | S | 0.19 | 792,942 | 148,439 | 368,872 | 1.2 M to 368.9 K (-68.25 %) |
| Aug 04 2009 | LJPC | LA JOLLA PHARMACEU ... | SUTTER MARTIN P | Director | Sell | S | 0.19 | 6,460 | 1,208 | 0 | 6.5 K to 0 (-100.00 %) |
| Aug 04 2009 | LJPC | LA JOLLA PHARMACEU ... | SUTTER MARTIN P | Director | Sell | S | 0.18 | 106,420 | 19,549 | 6,460 | 112.9 K to 6.5 K (-94.28 %) |
| Jun 25 2009 | LJPC | LA JOLLA PHARMACEU ... | SLOAN GAIL A | VP of Finance | Sell | S | 0.18 | 2,230 | 401 | 0 | 2.2 K to 0 (-100.00 %) |
| Jun 19 2009 | LJPC | LA JOLLA PHARMACEU ... | SLOAN GAIL A | VP of Finance | Sell | S | 0.20 | 4,914 | 983 | 1,860 | 6.8 K to 1.9 K (-72.54 %) |
| Jun 19 2009 | LJPC | LA JOLLA PHARMACEU ... | BIOMARIN PHARMACEUTICAL INC | 10% Owner | Sell | S | 0.21 | 2,546,958 | 524,419 | 4,466,387 | 7 M to 4.5 M (-36.32 %) |
| Jun 19 2009 | LJPC | LA JOLLA PHARMACEU ... | BIOMARIN PHARMACEUTICAL INC | 10% Owner | Sell | S | 0.21 | 2,198,825 | 460,874 | 7,013,345 | 9.2 M to 7 M (-23.87 %) |
| Jun 19 2009 | LJPC | LA JOLLA PHARMACEU ... | BIOMARIN PHARMACEUTICAL INC | 10% Owner | Sell | S | 0.22 | 960,950 | 216,022 | 9,212,170 | 10.2 M to 9.2 M (-9.45 %) |
| Jun 19 2009 | LJPC | LA JOLLA PHARMACEU ... | BIOMARIN PHARMACEUTICAL INC | 10% Owner | Option Exercise | C | 0.00 | 339,104 | 0 | 0 | |
| Jun 19 2009 | LJPC | LA JOLLA PHARMACEU ... | BIOMARIN PHARMACEUTICAL INC | 10% Owner | Buy | C | 0.00 | 10,173,120 | 0 | 10,173,120 | 0 to 10.2 M |
| Mar 05 2009 | LJPC | LA JOLLA PHARMACEU ... | Elchico Josefina T | VP Quality Operatio ... | Sell | S | 0.10 | 25,759 | 2,576 | 0 | 25.8 K to 0 (-100.00 %) |
| Feb 27 2009 | LJPC | LA JOLLA PHARMACEU ... | FILDES ROBERT PHD | Director | Sell | S | 0.05 | 16,612 | 869 | 0 | 16.6 K to 0 (-100.00 %) |
| Feb 27 2009 | LJPC | LA JOLLA PHARMACEU ... | SMITH CRAIG R | Director | Sell | S | 0.06 | 27,200 | 1,518 | 0 | 27.2 K to 0 (-100.00 %) |
| Feb 26 2009 | LJPC | LA JOLLA PHARMACEU ... | Topper James N | Director | Sell | S | 0.06 | 2,756,711 | 154,927 | 0 | 2.8 M to 0 (-100.00 %) |
| Feb 26 2009 | LJPC | LA JOLLA PHARMACEU ... | Topper James N | Director | Sell | S | 0.06 | 1,454,000 | 92,038 | 2,756,711 | 4.2 M to 2.8 M (-34.53 %) |
| Feb 26 2009 | LJPC | LA JOLLA PHARMACEU ... | Topper James N | Director | Sell | S | 0.07 | 1,662,000 | 120,827 | 4,210,711 | 5.9 M to 4.2 M (-28.30 %) |
| Feb 26 2009 | LJPC | LA JOLLA PHARMACEU ... | Frazier Healthcare V, LP | 10% Owner | Sell | S | 0.07 | 1,662,000 | 120,827 | 5,470,555 | 7.1 M to 5.5 M (-23.30 %) |
| Feb 26 2009 | LJPC | LA JOLLA PHARMACEU ... | ESSEX WOODLANDS HEALTH VENTURE ... | 10% Owner | Sell | S | 0.05 | 3,328,747 | 171,763 | 1,060,620 | 4.4 M to 1.1 M (-75.84 %) |
| Feb 26 2009 | LJPC | LA JOLLA PHARMACEU ... | ESSEX WOODLANDS HEALTH VENTURE ... | 10% Owner | Sell | S | 0.06 | 1,717,737 | 109,076 | 4,389,366 | 6.1 M to 4.4 M (-28.13 %) |
| Feb 26 2009 | LJPC | LA JOLLA PHARMACEU ... | ESSEX WOODLANDS HEALTH VENTURE ... | 10% Owner | Sell | S | 0.07 | 1,700,312 | 125,653 | 6,107,103 | 7.8 M to 6.1 M (-21.78 %) |
| Feb 26 2009 | LJPC | LA JOLLA PHARMACEU ... | ESSEX WOODLANDS HEALTH VENTURE ... | 10% Owner | Sell | S | 0.05 | 4,236,586 | 218,608 | 1,161,812 | 5.4 M to 1.2 M (-78.48 %) |
| Feb 26 2009 | LJPC | LA JOLLA PHARMACEU ... | ESSEX WOODLANDS HEALTH VENTURE ... | 10% Owner | Sell | S | 0.06 | 2,186,211 | 138,824 | 5,398,399 | 7.6 M to 5.4 M (-28.82 %) |
| Feb 26 2009 | LJPC | LA JOLLA PHARMACEU ... | ESSEX WOODLANDS HEALTH VENTURE ... | 10% Owner | Sell | S | 0.07 | 2,164,033 | 159,922 | 7,584,610 | 9.7 M to 7.6 M (-22.20 %) |
| Feb 13 2009 | LJPC | LA JOLLA PHARMACEU ... | Gonzalez Alejandro | 10% Owner | Sell | S | 0.20 | 8,205,692 | 1,641,138 | 0 | 8.2 M to 0 (-100.00 %) |
| Feb 12 2009 | LJPC | LA JOLLA PHARMACEU ... | Frazier Healthcare V, LP | 10% Owner | Option Exercise | P | 2.15 | 259,844 | 558,665 | 259,844 |